For a recently incarcerated patient with new‑onset psychosis who was started on haloperidol 5 mg daily and developed akathisia when the dose was increased to 10 mg, what specific PRN medication regimen (including drug names, doses, routes, frequency, and monitoring steps) should be ordered to manage the akathisia?

Immediate Management: Reduce Haloperidol and Add PRN Akathisia Treatment

For this patient experiencing akathisia from haloperidol 10 mg, immediately reduce the haloperidol dose back to 5 mg daily and add propranolol 10 mg PO three times daily PRN for akathisia symptoms, with the option to increase to 20-40 mg three times daily if needed. 1, 2

Understanding the Clinical Situation

This patient developed akathisia—a subjective feeling of inner restlessness with inability to sit still—when haloperidol was increased from 5 mg to 10 mg. This is a common and distressing extrapyramidal side effect that occurs in the early phases of antipsychotic treatment, particularly with high-potency conventional antipsychotics like haloperidol 3, 2. The akathisia is dose-related in this case, as symptoms appeared specifically after dose escalation.

Step 1: Reduce the Antipsychotic Dose

Reduce haloperidol from 10 mg back to 5 mg daily immediately. This is the first-line intervention for akathisia 1, 2. Since the patient tolerated 5 mg without akathisia, returning to this dose addresses the root cause while maintaining antipsychotic coverage for the new-onset psychosis.

Step 2: Add PRN Medication for Akathisia

Primary PRN Option: Propranolol (Beta-Blocker)

Order: Propranolol 10 mg PO three times daily PRN for akathisia

• Start with 10 mg TID PRN
• May increase to 20 mg TID after 2-3 days if inadequate response
• Maximum effective dose typically 40 mg TID (120 mg/day total)
• Monitor blood pressure and heart rate before each dose 2, 4

Contraindications to check: Asthma, COPD, heart block, bradycardia, hypotension 2

Propranolol has the strongest evidence base for akathisia treatment and was effective even in treatment-resistant cases 2, 4, 5. The evidence shows gradual resolution over days to weeks with dose titration 4.

Alternative PRN Option: Benzodiazepines

Order: Lorazepam 1-2 mg PO/IM every 4-6 hours PRN for akathisia

• Use if propranolol is contraindicated or ineffective
• Provides more immediate relief but carries sedation and dependence risks
• Particularly useful if patient also has significant anxiety or agitation 1, 2

The guidelines support benzodiazepines as an alternative treatment for akathisia, with lorazepam 2-4 mg being as effective as haloperidol for agitation control 6.

Third-Line PRN Option: Anticholinergics

Order: Benztropine 1-2 mg PO/IM twice daily PRN

• Less consistently effective for akathisia compared to parkinsonism or dystonia
• May help if patient develops other extrapyramidal symptoms
• Avoid in elderly or those with anticholinergic burden 1, 2

Important caveat: Anticholinergics are NOT first-line for akathisia specifically—they work better for dystonia and drug-induced parkinsonism 3, 1. However, they can be tried if beta-blockers and benzodiazepines fail 2.

Step 3: Monitoring Protocol

Daily for first week:

• Assess akathisia severity using objective criteria (can patient sit still for 5 minutes? pacing? leg movements?)
• Blood pressure and heart rate if using propranolol
• Mental status and psychotic symptoms to ensure adequate antipsychotic coverage at reduced dose

Weekly thereafter:

• Reassess need for PRN medications
• Consider whether akathisia has resolved enough to discontinue adjuvant treatment
• Monitor for other extrapyramidal symptoms (dystonia, parkinsonism)

Step 4: Long-Term Considerations

If akathisia persists despite dose reduction and adjuvant medications, or if psychosis worsens at the lower haloperidol dose, consider switching to an atypical antipsychotic with lower akathisia risk 7, 1:

• Quetiapine 25-50 mg PO twice daily (very low extrapyramidal symptom risk) 8, 9
• Olanzapine 5-10 mg PO daily (lower movement disorder risk than haloperidol) 8, 9
• Risperidone 0.5-1 mg PO twice daily (lower risk at doses <6 mg/day) 8, 9

Ziprasidone notably has minimal extrapyramidal symptoms including akathisia in the evidence 6, but requires cardiac monitoring for QTc prolongation 10.

Critical Pitfalls to Avoid

1. Do not increase haloperidol further while akathisia is present—this will worsen symptoms 2
2. Do not mistake akathisia for worsening psychotic agitation—this commonly leads to inappropriate dose increases 3, 2
3. Do not use anticholinergics as first-line for akathisia—they are less effective than beta-blockers or benzodiazepines for this specific symptom 1, 2
4. Do not continue adjuvant medications indefinitely—reassess need regularly as akathisia often resolves with time at stable doses 2
5. Monitor for paradoxical agitation with benzodiazepines—occurs in ~10% of patients 8

Specific Orders Summary

Immediate orders:

1. Haloperidol 5 mg PO daily (reduced from 10 mg)
2. Propranolol 10 mg PO TID PRN for akathisia (hold for SBP <100 or HR <60)
3. Alternative: Lorazepam 1-2 mg PO/IM every 4-6 hours PRN for akathisia (if propranolol contraindicated)
4. Monitor vital signs before each propranolol dose
5. Assess akathisia symptoms daily

Titration plan:

• If akathisia persists after 2-3 days, increase propranolol to 20 mg PO TID PRN
• If still inadequate after another 2-3 days, increase to 40 mg PO TID PRN (maximum)
• If no improvement after 1 week at maximum propranolol, consider adding lorazepam or switching antipsychotic

This approach prioritizes the patient's quality of life by addressing the distressing akathisia while maintaining treatment for the underlying psychosis, using the most evidence-based interventions in a stepwise manner 1, 2.